Gilead To Donate 1.5M Doses Of Experimental Coronavirus Treatment
Gilead Sciences is donating 1.5M doses of remdesivir, a drug aimed at lessening symptoms of COVID, to patients with severe symptoms.
Gilead Sciences is donating 1.5M doses of remdesivir, a drug aimed at lessening symptoms of COVID, to patients with severe symptoms.